Independent director of Guangdong Jiangxi Wannianqing Cement Co.Ltd(000789) Pharmaceutical Co., Ltd
On relevant matters of the sixth meeting of the second board of directors
Prior approval opinion
As an independent director of Guangdong Jiangxi Wannianqing Cement Co.Ltd(000789) Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”), we reviewed relevant materials in accordance with the company law of the people’s Republic of China, the guidelines for self discipline supervision of listed companies on Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, the articles of association of the company and the detailed rules for the work of independent directors, We hereby express our prior approval opinions on the relevant matters considered at the sixth meeting of the second board of directors as follows:
1、 Prior approval opinions on the company’s reappointment of the audit institution in 2022
After verification, Huaxing Certified Public Accountants (special general partnership) is a certified public accountant with securities, futures and other related business qualifications, with many years of experience and ability to provide audit services for listed companies, investor protection ability, integrity and independence. It can provide true and fair audit services for the company, meet the requirements of the company’s audit work in 2022 and meet the needs of the company’s business development. Therefore, we agreed to continue to appoint Huaxing Certified Public Accountants (special general partnership) as the company’s audit institution in 2022, and agreed to submit the proposal on renewing the company’s audit institution in 2022 to the sixth meeting of the second board of directors for deliberation. (no text below)
(there is no text on this page, which is the signature page of the prior approval opinions of the independent directors of Guangdong Jiangxi Wannianqing Cement Co.Ltd(000789) Pharmaceutical Co., Ltd. on matters related to the sixth meeting of the second board of directors) signed by the independent directors:
Su Xudong, Zhu Renhong, Yang Nong
April 20, 2002
